What are the risks of antibiotic therapy failure in women with tubo-ovarian abscesses?

Published On: 21 Mar, 2024 11:53 AM | Updated On: 21 Mar, 2024 12:10 PM

What are the risks of antibiotic therapy failure in women with tubo-ovarian abscesses?

A tubo-ovarian abscess (TOA) presents a challenging clinical scenario, with treatment options ranging from medical therapy with antibiotics to surgical drainage. However, determining the appropriate course of action remains a complex decision, as the criteria for surgical intervention still need to be precisely defined. The present study identifies the risk factors associated with antibiotic therapy failure in women with TOA through a comprehensive literature review-

The study describes-

  • It included 29 studies, with 2890 women. 
  • The age, abscess size, history of intrauterine device use, postmenopausal status, history of diabetes mellitus, fever, white blood cell count, erythrocyte sedimentation rate, C-reactive protein level, and history of pelvic inflammatory disease are the significant risk factors for antibiotic therapy failure in women with TOA.

The findings from this study underline the risk factors for antibiotic therapy failure in women with TOA, thereby guiding clinicians in making informed decisions regarding patient care.

Kinay T, Akay A, Aksoy M, Balkan FC, Ustun YE. Risk factors for antibiotic therapy failure in women with tubo-ovarian abscess: A systematic review and meta-analysis. Journal of Obstetrics and Gynaecology Research. 2024; 50(3): 298-312. https://doi.org/10.1111/jog.15870

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks